Montes Archimedes Acquisition Corp.
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $410.72M |
|---|---|
| IPO Date | Oct 7, 2020 |
| CEO | James C. Momtazee |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare |
| IPO Geography | Global |
| Target Company | Roivant Sciences |
| Deal Announced | May 3, 2021 |
| Deal Size, $M | $5,000.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 28, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 30, 2021 |
Formerly MAAC
ROIV
ROIVW
| Price | $11.49 |
|---|---|
| Last closing price | $11.31 |
| H/L, today | $11.24 / $11.51 |
| H/L, 52-week | $4.73 / $13.24 |
| Volume, today | 3,068,761 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Montes Archimedes Acquisition Corp.:
- Structure and cap table
- 4 directors & officers
- 25 filings and events
- 2 underwriters
- 9 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| James C. Momtazee | 48 | CEO and Director |
| Maria C. Walker | 55 | CFO |
| George Barrett | 65 | Director |
| Steve Oesterle | 69 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Deal
Sign in to view merger details and deal financials.